These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 9488201)

  • 1. Impairment and restoration of nitric oxide-dependent vasodilation in cardiovascular disease.
    Lyons D
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S101-9. PubMed ID: 9488201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type I receptor blocker and endothelial function in humans: role of nitric oxide and oxidative stress.
    Higashi Y; Chayama K; Yoshizumi M
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):133-48. PubMed ID: 15853700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
    Hornig B; Arakawa N; Drexler H
    Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide.
    Landmesser U; Drexler H
    J Hypertens Suppl; 2006 Mar; 24(1):S39-43. PubMed ID: 16601572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
    Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysiology and clinical implications.
    Rongen GA; Smits P; Thien T
    Neth J Med; 1994 Jan; 44(1):26-35. PubMed ID: 8202203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.
    van Etten RW; de Koning EJ; Verhaar MC; Gaillard CA; Rabelink TJ
    Diabetologia; 2002 Jul; 45(7):1004-10. PubMed ID: 12136399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
    Ruschitzka FT; Lüscher TF
    Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.
    Mombouli JV
    Drugs; 1997; 54 Suppl 5():12-22. PubMed ID: 9429841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
    Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Working under pressure: the vascular endothelium in arterial hypertension.
    Spieker LE; Noll G; Ruschitzka FT; Maier W; Lüscher TF
    J Hum Hypertens; 2000; 14(10-11):617-30. PubMed ID: 11095155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
    Zeiher AM; Schächinger V
    Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise and the nitric oxide vasodilator system.
    Maiorana A; O'Driscoll G; Taylor R; Green D
    Sports Med; 2003; 33(14):1013-35. PubMed ID: 14599231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study.
    Higashi Y; Sasaki S; Nakagawa K; Ueda T; Yoshimizu A; Kurisu S; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2000 Feb; 35(2):284-91. PubMed ID: 10676671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation.
    Simonsen U; Rodriguez-Rodriguez R; Dalsgaard T; Buus NH; Stankevicius E
    Pharmacol Rep; 2009; 61(1):105-15. PubMed ID: 19307698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus.
    Williams SB; Cusco JA; Roddy MA; Johnstone MT; Creager MA
    J Am Coll Cardiol; 1996 Mar; 27(3):567-74. PubMed ID: 8606266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial function and dysfunction in heart failure.
    Ferrari R; Bachetti T; Agnoletti L; Comini L; Curello S
    Eur Heart J; 1998 Jul; 19 Suppl G():G41-7. PubMed ID: 9717055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome.
    Kagota S; Fukushima K; Umetani K; Tada Y; Nejime N; Nakamura K; Mori H; Sugimura K; Kunitomo M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1035-43. PubMed ID: 20659132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.